Top-News
Biotechnologie USA

VistaGen Therapeutics News

Aktie
WKN:  A3EHA1 ISIN:  US92840H4002 US-Symbol:  VTGN
3,2137 €
+0,0463 €
+1,46%
3,48 $ 28.06.24
Handeln Depot/Watchlist
Aktienanzahl *
6,89 Mio.
Marktkapitalisierung *
21,09 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 07.06.2023

VistaGen Therapeutics News

07.12.23 - PR Newswire
Thinking about trading options or stock in Adobe, Taiwan Semiconductor, AerSale Corp, Vistagen Therapeutics, or Chewy Inc?
Thinking about trading options or stock in Adobe, Taiwan Semiconductor, AerSale Corp, Vistagen Therapeutics, or Chewy Inc? PR Newswire
17.10.23 - PR Newswire
Thinking about buying stock in Faraday Future Intelligent Electric, Processa Pharmaceuticals, ZW Data Action Technologies, Neuroone Medical Technologies, or Vistagen Therapeutics?
Thinking about buying stock in Faraday Future Intelligent Electric, Processa Pharmaceuticals, ZW Data Action Technologies, Neuroone Medical Technologies, or Vistagen ...
06.10.23 - PR Newswire
Thinking about buying stock in Profire Energy, Vistagen Therapeutics, OKYO Pharma, Nuscale Power, or Femasys?
Thinking about buying stock in Profire Energy, Vistagen Therapeutics, OKYO Pharma, Nuscale Power, or Femasys? PR Newswire
15.08.23 - PR Newswire
Thinking about trading options or stock in Vistagen Therapeutics, Super Micro Computer, American Superconductor Corporation, Eli Lilly, or Telesat Corp?
Thinking about trading options or stock in Vistagen Therapeutics, Super Micro Computer, American Superconductor Corporation, Eli Lilly, or Telesat Corp? PR Newswire
10.08.23 - PR Newswire
Thinking about buying stock in Vistagen Therapeutics, Origin Materials, MedAvail Holdings, United States Lime & Minerals, or Adhera Therapeutics?
Thinking about buying stock in Vistagen Therapeutics, Origin Materials, MedAvail Holdings, United States Lime & Minerals, or Adhera Therapeutics? PR Newswire
08.08.23 - PR Newswire
Thinking about buying stock in FlexShopper, HH&L Acquisition, Vistagen Therapeutics, Vivos Therapeutics, or Missfresh?
Thinking about buying stock in FlexShopper, HH&L Acquisition, Vistagen Therapeutics, Vivos Therapeutics, or Missfresh? PR Newswire
22.03.23 - PR Newswire
Thinking about buying stock in Vistagen Therapeutics, NVIDIA, SoFi Technologies, Carnival Corp, or Nike?
Thinking about buying stock in Vistagen Therapeutics, NVIDIA, SoFi Technologies, Carnival Corp, or Nike? PR Newswire
19.08.22 - PR Newswire
Thinking about buying stock in Endo International, Vistagen Therapeutics, Applied DNA Sciences, Ford Motor, or Mobiquity Technologies?
Thinking about buying stock in Endo International, Vistagen Therapeutics, Applied DNA Sciences, Ford Motor, or Mobiquity Technologies? PR Newswire
26.07.22 - PR Newswire
Thinking about buying stock in Humanigen, Versus Systems, Shopify, Vinco Ventures, or Vistagen Therapeutics?
Thinking about buying stock in Humanigen, Versus Systems, Shopify, Vinco Ventures, or Vistagen Therapeutics? PR Newswire
25.07.22 - PR Newswire
Thinking about buying stock in Exela Technologies, Redbox Entertainment, Vistagen Therapeutics, Toughbuilt Industries, or Infrastructure & Energy Alternatives?
Thinking about buying stock in Exela Technologies, Redbox Entertainment, Vistagen Therapeutics, Toughbuilt Industries, or Infrastructure & Energy Alternatives? PR Newswire
22.07.22 - PR Newswire
Thinking about buying stock in Snap, Vistagen Therapeutics, Blue Hat, Rivian Automotive, or AT&T?
Thinking about buying stock in Snap, Vistagen Therapeutics, Blue Hat, Rivian Automotive, or AT&T? PR Newswire
01.07.21 - PR Newswire
Thinking about buying stock in Bridgeline Digital, Seelos Therapeutics, Vistagen Therapeutics, BioLineRx, or Entera Bio?
Thinking about buying stock in Bridgeline Digital, Seelos Therapeutics, Vistagen Therapeutics, BioLineRx, or Entera Bio? PR Newswire
25.05.21 - PR Newswire
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle?
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle? PR Newswire
20.05.21 - PR Newswire
Thinking about buying stock in Virgin Galactic, Vistagen Therapeutics, PDS Biotechnology, Super League Gaming, or Allogene Therapeutics?
Thinking about buying stock in Virgin Galactic, Vistagen Therapeutics, PDS Biotechnology, Super League Gaming, or Allogene Therapeutics? PR Newswire
18.02.21 - PR Newswire
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals?
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals? PR Newswire
18.12.20 - PR Newswire
Thinking about buying stock in Vistagen Therapeutics, Adapthealth, PainReform, Arbutus Biopharma, or AIM ImmunoTech?
Thinking about buying stock in Vistagen Therapeutics, Adapthealth, PainReform, Arbutus Biopharma, or AIM ImmunoTech? PR Newswire
10.12.20 - PR Newswire
VistaGen Announces Korean Intellectual Property Office Decision to Grant PH10 Patent for Treatment of Depression
VistaGen Announces Korean Intellectual Property Office Decision to Grant PH10 Patent for Treatment of Depression Previously completed Phase 2A clinical study of PH10 ...
01.12.20 - PR Newswire
VistaGen Therapeutics Expands R&D Team with Appointment of Louis Monti, M.D., Ph.D., Pioneer in the Development of Neuroactive Steroids known as Pherines as Potential Treatments for Anxiety and Depression Disorders, as Vice President, Translational Medicine
VistaGen Therapeutics Expands R&D Team with Appointment of Louis Monti, M.D., Ph.D., Pioneer in the Development of Neuroactive Steroids known as Pherines as Potential ...
12.11.20 - PR Newswire
VistaGen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on its CNS Pipeline and Business Progress
VistaGen Therapeutics Reports Fiscal 2021 Second Quarter Financial Results and Provides Highlights on its CNS Pipeline and Business Progress Positive FDA Meeting Sets Key ...
12.11.20 - PR Newswire
VistaGen Reports Positive Preclinical Data Differentiating Mechanism of Action of PH94B from Risk-Ridden Benzodiazepines
VistaGen Reports Positive Preclinical Data Differentiating Mechanism of Action of PH94B from Risk-​Ridden Benzodiazepines New electrophysiological data demonstrate that ...

Newssuche

Videos

newspaper
03.07.24 +3,08%
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »